TheSocialMedwork reveals Aimovig is the most sought after drug in the Middle East

657 people in the region interested in the life-changing migraine drug in one month.

TheSocialMedwork has revealed Aimovig, the transformative migraine drug, is the most sought after medicine on their site from patients in the Middle East, with 657 people seeking information about this medicine in just 30 days from July 5th to August 5th. This is followed by Ocrevus (used to treat multiple sclerosis – 569 people), Spinraza (used to treat spinal muscular atrophy – 525 people), Venclexta (a medication used for the treatment of chronic lymphocytic leukemia – 273 people) and Radicut (used to treat amyotrophic lateral sclerosis, also known as motor neurone disease – 190 people).

TheSocialMedwork helps people access medicines approved by foreign health regulatory authorities, such as the U.S. FDA and EMA and not currently available in the Middle East. Using existing legal structures for ‘named patient’ imports, the medical startup, which is fully licensed and regulated by the Ministry of Health in The Netherlands, has delivered to patients across the GCC medicines for Aimovig (erenumab), Generic Edaravone and Radicut (edaravone) so far.

Aimovig (erenumab) was the most sought after medicine in Saudi Arabia, Kuwait, Bahrain, Qatar, Lebanon, and Iran. In 2018, order requests for the medicine were processed from patients in Saudi Arabia, UAE and Kuwait. Venclexta, the medicine used to treat chronic lymphocytic leukemia, was also in the top five sought after medicines from the Kingdom with 20 people expressing interest last year.

In each country mentioned, the requested drug is currently unavailable meaning patients would have to travel to another country to obtain treatment. Now, with TheSocialMedwork people can get a prescription from their treating doctor and order it online. TheSocialMedwork will help guide each person through importing it and oversees all aspects of the delivery and customs process. The organisations ensures the medicine is ready for administration by a healthcare provider and that every package arrives in perfect condition – with all specialist shipping conditions like refrigerated packaging (called cold chain shipping) being handled by the team of qualified pharmacists, logistic experts and healthcare professionals.

Aimovig (erenumab) is just one of the 60 medicines available on the platform, which has delivered almost 4,000 medicines to patients in 70 countries across the world. Sufferers of debilitating and chronic diseases can now access vital new treatments months, even years, faster and no longer need complex trips abroad to seek the latest care.

Over 20% of the TheSocialMedwork’s business is from helping people in the Middle East and demand for medicines via the platform is growing rapidly.

The Dutch healthcare startup which was founded in 2014 by Sjaak Vink, James Heywood, Bernard Muller, himself an ALS patient, and Katrin Schepp, and dispenses medicines only with a valid prescription and can deliver to the patient, a pharmacy or hospital – depending on local regulations.

For a full list of medicines available and information on how to access them, visit: https://thesocialmedwork.com/

**Please note, Thumbay Group, Gulf Medical University, and HEALTH magazine are not liable nor responsible for the facts, figures, and overall content of the press releases on our portal.

Related Articles